冠昊生物
(300238)
| 流通市值：40.17亿 | | | 总市值：40.17亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 94,797,135.39 | 377,483,103.8 | 278,135,520.4 | 189,698,181.61 |
| 营业收入 | 94,797,135.39 | 377,483,103.8 | 278,135,520.4 | 189,698,181.61 |
| 二、营业总成本 | 76,040,276.86 | 334,942,285.38 | 249,921,949.86 | 160,966,865.61 |
| 营业成本 | 21,756,284.1 | 77,525,843.69 | 59,418,347.34 | 42,079,822.97 |
| 税金及附加 | 1,086,779.49 | 5,256,670.06 | 2,856,459.25 | 1,948,613.09 |
| 销售费用 | 31,391,817.06 | 157,460,394.2 | 118,255,574.23 | 73,734,951.86 |
| 管理费用 | 13,010,932.5 | 57,170,350.92 | 40,650,655.56 | 26,766,060.42 |
| 研发费用 | 7,798,700.14 | 36,164,958.42 | 28,093,493.13 | 16,028,573.85 |
| 财务费用 | 995,763.57 | 1,364,068.09 | 647,420.35 | 408,843.42 |
| 其中:利息费用 | 1,022,766.68 | 1,030,373.62 | 459,933.35 | 313,083.35 |
| 其中:利息收入 | 187,266.08 | 665,099.62 | 470,015.14 | 275,495.58 |
| 加:投资收益 | -120,731.4 | 606,241.58 | 805,725.68 | -404,010.79 |
| 资产处置收益 | -3,159.53 | 32,334.57 | 1,470 | 885 |
| 资产减值损失(新) | -20,090.05 | -17,072,238.17 | 35,412.54 | 113,559.74 |
| 信用减值损失(新) | -1,227,677.9 | -7,443,414.67 | -6,460,317.84 | -4,437,590.41 |
| 其他收益 | 463,223.77 | 9,579,849.74 | 8,901,376.79 | 2,052,158.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 17,848,423.42 | 28,243,591.47 | 31,497,237.71 | 26,056,317.79 |
| 加:营业外收入 | 1,320,317.23 | 23,603.65 | 11,592.96 | 2,285.03 |
| 减:营业外支出 | 62,127.92 | 247,916.82 | 174,832.72 | 180,190.86 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 19,106,612.73 | 28,019,278.3 | 31,333,997.95 | 25,878,411.96 |
| 减:所得税费用 | 4,378,826.18 | 11,411,784.85 | 10,675,074.65 | 9,119,075.73 |
| 六、净利润 | 14,727,786.55 | 16,607,493.45 | 20,658,923.3 | 16,759,336.23 |
| 持续经营净利润 | 14,727,786.55 | 16,607,493.45 | 20,658,923.3 | 16,759,336.23 |
| 归属于母公司股东的净利润 | 14,866,096.67 | 27,416,909.65 | 27,836,338.53 | 20,148,444.33 |
| 少数股东损益 | -138,310.12 | -10,809,416.2 | -7,177,415.23 | -3,389,108.1 |
| (一)基本每股收益 | 0.06 | 0.1 | 0.1 | 0.08 |
| (二)稀释每股收益 | 0.06 | 0.1 | 0.1 | 0.08 |
| 八、其他综合收益 | -16,948.91 | 74,362.59 | -112,095.04 | -41,348.81 |
| 归属于母公司股东的其他综合收益 | -16,948.91 | 74,362.59 | -112,095.04 | -41,348.81 |
| 九、综合收益总额 | 14,710,837.64 | 16,681,856.04 | 20,546,828.26 | 16,717,987.42 |
| 归属于母公司股东的综合收益总额 | 14,849,147.76 | 27,491,272.24 | 27,724,243.49 | 20,107,095.52 |
| 归属于少数股东的综合收益总额 | -138,310.12 | -10,809,416.2 | -7,177,415.23 | -3,389,108.1 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |